Drug inspectors in Telangana detect violations at 75 pharmacies selling weight-loss drugs like Semaglutide and Tirzepatide without prescriptions.

A statewide enforcement drive by the Drugs Control Administration Telangana has uncovered widespread irregularities in the sale of weight-loss medications, with violations detected at 75 pharmacies.

Officials said several outlets were found dispensing prescription-only drugs without valid medical prescriptions and, in some instances, operating without a qualified pharmacist on duty. The crackdown focused on high-demand drugs such as Semaglutide and Tirzepatide, commonly sold under popular brand names.

Inspectors reported multiple lapses, including failure to maintain records, issuing medicines without bills, and inconsistencies in purchase and sales documentation. Authorities also flagged concerns about counterfeit or substandard versions of these drugs entering the market amid rising demand.

Health experts warn that unsupervised use of such medications can lead to serious side effects, including nausea, dehydration, and complications affecting the pancreas or kidneys. Improper dosage or fake formulations can further increase risks.

The crackdown highlights growing concerns over self-medication and online-driven demand for rapid weight-loss solutions. For consumers, the takeaway is clear—these drugs should only be used under strict medical supervision, and purchasing from verified pharmacies is essential to avoid potentially dangerous outcomes.